You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Innovative Device to Improve Safety of Preparing and Administering Chemotherapy

    SBC: J & J Solutions, Inc.            Topic: 102

    DESCRIPTION provided by applicant Manual drug compounding of chemotherapy medications permits deadly dosing errors and toxic drug exposure and therefore poses unnecessary risks to patients and healthcare professionals Some robotic compounding devices have been developed in response however poor drug containment safety capabilities and prohibitive cost and size have limited widespread adoptio ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Unified high performance analysis of imaging biomarkers for Alzheimer's disease

    SBC: PIERSON BRAIN IMAGE ANALYSIS            Topic: NIA

    DESCRIPTION provided by applicant Alzheimerandapos s disease is a neurodegenerative disease of the brain causing impairments to memory and cognitive functions eventually leading to death The causes of Alzheimerandapos s disease and mechanisms of disease progression are not fully understood but an enormous amount of effort is being focused on the issues in research and pharmacologic intervent ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Development of a Porcine Model of Duchenne Muscular Dystrophy

    SBC: EXEMPLAR GENETICS, LLC            Topic: NIAMS

    DESCRIPTIONprovided by applicantDuchenne muscular dystrophyDMDis an X linked recessive disorder caused by mutations in the DMD gene with a prevalence ofinmale birthsThe consequent loss of functional dystrophin results in the progressive degeneration of skeletal and cardiac muscleDespite significant progress in our understanding of this disease and advances in the development of new therapeutic app ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Nutritional Intervention for Age Related Muscular Function and Strength Losses

    SBC: MTI Biotech Incorporated            Topic: NIA

    DESCRIPTION provided by applicant Sarcopenia defined as age related loss of muscle mass and muscle function and strength is very prevalent among the elderly Sarcopenia is one of the largest public health problems facing a rapidly increasing aging population in the United States and leads to increased incidence of falls fractures and associated morbidities Previous observations from our la ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  5. RADIOGRAPHIC CONTRAST TO DIFFERENTIATE CAVITATED FROM NON-CAVITATED DENTAL CARIES

    SBC: FIREFLY HEALTH INNOVATIONS NE, INC.            Topic: NIDCR

    DESCRIPTION provided by applicant This project aims to improve the accuracy of tests for early tooth decay dental caries specifically for interproximal surfaces where the posterior teeth abut one another In these regions there is no physical space to visually inspect or probe for caries Instead dentists rely on bitewing X rays BWs But dentists cannot tell whether lucencies observed ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Innovative Device to Improve Safety of Preparing and Administering Chemotherapy

    SBC: J & J Solutions, Inc.            Topic: NCI

    ? DESCRIPTION (provided by applicant): Manual drug compounding of chemotherapy medications permits deadly dosing errors and toxic drug exposure and therefore poses unnecessary risks to patients and healthcare professionals. Some robotic compounding devices have been developed in response; however, poor drug containment safety capabilities and prohibitive cost and size have limited widespread a ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government